• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDRH (ODE and OIR) 510(k) decisions meeting MDUFA goals during the month

Dictionary: The Medical Device User Fee Amendments (MDUFA II) require FDA to pursue a comprehensive set of device review performance goals, intended to significantly improve the timeliness and predictability of FDA’s review of new devices. MDUFA II performance goals are measured by receipt cohort. By using the decision cohort, this measure provides a different approach to monitoring MDUFA related 510(k) performance goals. The measure tracks the number of 510(k) decisions made during the month that were within 90 FDA days. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device (21 CFR 807.92(a)(3)) that is not subject to a Premarket Approval (PMA).

Submitters must compare their device to one or more similar legally marketed devices and make and support their substantial equivalency (SE) claims. A legally marketed device, as described in 21 CFR 807.92(a)(3), is a device that was legally marketed prior to May 28, 1976 (preamendments device), for which a PMA is not required, or a device which has been reclassified from Class III to Class II or I, or a device which has been found SE through the 510(k) process. The legally marketed device(s) to which equivalence is drawn is commonly known as the "predicate." Although devices recently cleared under 510(k) are often selected as the predicate to which equivalence is claimed, any legally marketed device may be used as a predicate.

Information is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20119094
Nov 20119092
Dec 20119095
Jan 20129091
Feb 20129097
Mar 20129094
Apr 20129097
May 20129094
Jun 20129097
Jul 20129095
Aug 20129097
Sep 20129097

FY 2012 Total: 95%

Number of CDRH (ODE and OIR) 510(k) decisions made in 90 days or less during the month (meeting goal)

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A248
Nov 2011N/A240
Dec 2011N/A321
Jan 2012N/A215
Feb 2012N/A243
Mar 2012N/A269
Apr 2012N/A258
May 2012N/A297
Jun 2012N/A288
Jul 2012N/A268
Aug 2012N/A266
Sep 2012N/A253

FY 2012 Total: 3,166

Total number of CDRH (ODE and OIR) 510(k) decisions made during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A265
Nov 2011N/A260
Dec 2011N/A338
Jan 2012N/A235
Feb 2012N/A250
Mar 2012N/A286
Apr 2012N/A267
May 2012N/A317
Jun 2012N/A296
Jul 2012N/A281
Aug 2012N/A275
Sep 2012N/A262

FY 2012 Total: 3,332

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.